Julianne Bruno Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Julianne Bruno is Chief Operating Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 7,062 shares of CRSP, which is worth approximately $328,877. The most recent transaction as insider was on Feb 19, 2025, when has been sold 333 shares (Common Shares) at a price of $52.8 per share, resulting in proceeds of $17,582. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.06K
4.7% 3M change
n/a 12M change
Total Value Held $328,877

Julianne Bruno Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
SELL
Open market or private sale
$17,582 $52.8 p/Share
333 Reduced 4.5%
7,062 Common Shares
Feb 18 2025
BUY
Exercise of conversion of derivative security
-
650 Added 8.08%
7,395 Common Shares
Jun 21 2024
SELL
Open market or private sale
$188,798 $56.09 p/Share
3,366 Reduced 33.29%
6,745 Common Shares
Jun 20 2024
BUY
Exercise of conversion of derivative security
-
7,000 Added 40.91%
10,111 Common Shares
JB

Julianne Bruno

Chief Operating Officer
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP